S

Savara

D
SVRA
USD
0.21
(4.7351%)
Market Closed
48,162.00
Volume
-0.455
EPS
-
Div Yield
-11.059524
P/E
764,569,800.94
Market Cap
Today
4.7351%
1 Week
9.681%
1 Month
4.382%
6 Months
-4.424%
12 Months
20.806%
Year To Date
-1.380%
All Time
-99.138%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ARWR
0.35
(1.6851%)
USD
I
INCY
1.67
(2.5625%)
USD
N
NBIX
0.63
(0.5258%)
USD
REGN
REGN
11.33
(0.9948%)
USD
VRTX
VRTX
3.93
(0.8292%)
USD

Title:
Savara

Sector:
Healthcare
Industry:
Biotechnology
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Do you need help or have a question?
Contact Us